Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. (2022)
Attributed to:
Molecular Mechanisms of Cell Death
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021015161
PubMed Identifier: 35134130
Publication URI: http://europepmc.org/abstract/MED/35134130
Type: Journal Article/Review
Volume: 139
Parent Publication: Blood
Issue: 16
ISSN: 0006-4971